Amanote Research
Register
Sign In
Debranding - The Unacceptable Face of Pharma?
Prescriber
- United Kingdom
doi 10.1002/psb.1554
Full Text
Open PDF
Abstract
Available in
full text
Categories
Pharmacology
Date
April 1, 2017
Authors
Rob Munro
Publisher
Wiley
Related search
The Costs of Vilifying Pharma
CMAJ
Medicine
The Status Quo Is Unacceptable!
International Nonwovens Journal
Unnecessary Uncertainty Is Unacceptable
CMAJ
Medicine
Pharma News
Psychopraxis
Sending Pharma Better Signals
Science
Multidisciplinary
Philosophy of Science
History
CPhI Pharma Awards
Chemical and Engineering News
Chemical Engineering
Pharma-Standard Supplements
Can Drug Price Hikes via Debranding Be Prevented?
Prescriber
Pharmacology
Cheng Yi Pharma
Chemical and Engineering News
Chemical Engineering